Because ICAM1 appears in senile plaques of patients with Alzheimer’s disease20, ICAM1 downregulation implied a possible effect of (S)-reticuline 7-O-sulphate as a drug for this disease. This evidence concerns the gene ICAM1 and Senile plaques.